LBP AM’s West Pharmaceutical WST Stock Holding History

LBP AM’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$534K	Sell	2,131 -19,878	-90%	-$4.95M	0.01%	368
2025 Q4	$6.06M	Buy	22,009 +19,819	+905%	+$5.42M	0.07%	213
2025 Q3	$575K	Buy	+2,190	New	+$532K	0.01%	360
2024 Q2	–	Sell	-3,662	Closed	-$1.45M	–	358
2024 Q1	$1.45M	Sell	3,662 -372	-9%	-$138K	0.06%	195
2023 Q4	$1.42M	Sell	4,034 -1,038	-20%	-$367K	0.03%	294
2023 Q3	$1.9M	Buy	5,072 +11	+0.2%	+$4.25K	0.04%	295
2023 Q2	$1.94M	Sell	5,061 -12,650	-71%	-$4.52M	0.05%	261
2023 Q1	$6.14M	Buy	17,711 +3,535	+25%	+$1.03M	0.16%	136
2022 Q4	$3.34M	Buy	+14,176	New	+$3.36M	0.1%	215

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LBP AM's WST Position: Q1 2026 in Review

LBP AM reduced its West Pharmaceutical (WST) stake by 90% in Q1 2026, selling an estimated $4.95M and leaving 2,131 shares worth $534K. The position accounts for 0.01% of the portfolio, ranked #368.

LBP AM first reported a position in WST in Q4 2022 and has held it in 9 quarters since. The position peaked at $6.14M in Q1 2023. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

LBP AM held 2,131 shares of West Pharmaceutical worth $534K as of Q1 2026.
LBP AM sold 19,878 West Pharmaceutical shares in Q1 2026, an estimated $4.95M.
West Pharmaceutical made up 0.01% of LBP AM's portfolio in Q1 2026, its #368 holding.
LBP AM first reported a position in West Pharmaceutical in Q4 2022 and has held it in 9 quarters since.
LBP AM's West Pharmaceutical position peaked at $6.14M in Q1 2023.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.